Loading clinical trials...
Loading clinical trials...
Ulinastatin reduce the amount of bleeding and fibrinolysis in high risk patients undergoing off-pump coronary bypass surgery (OPCAB).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Yonsei University
NCT04598191 · Coronary Artery Occlusive Disease
NCT03699462 · Coronary Artery Occlusive Disease(CAOD)
NCT02456493 · Coronary Artery Occlusive Disease
NCT01051206 · Coronary Artery Occlusive Disease
Severance Hospital, Yonsei University College of Medicine
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions